miR-34a,.

Aleksandra Kopacz1, Damian Kloska1, Anna Bar2

  • 1Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.

概括

微RNA-34a (miR-34a) 通过调节NRF2驱动内皮细胞衰老和腹腔大动脉动脉瘤 (AAA) 的发展. 抑制miR-34a可以防止AAA,这表明它具有治疗潜力.